All Stories

  1. Role of CXCL13 in the formation of the meningeal tertiary lymphoid organ in multiple sclerosis

    Article • F1000Research, April 2018, Faculty of 1000, Ltd.

    MD Ana C Londono, Dr. Carlos A Mora

  2. The ultimate goal in therapy of MS is Evidence of Disease Control (EDC) instead of NEDA

    Article • F1000Research, April 2017, Faculty of 1000, Ltd.

    MD Ana C Londono, Dr. Carlos A Mora

  3. bone marrow transplant multiple sclerosis

    Article • Journal of Clinical & Cellular Immunology, January 2016, OMICS Publishing Group

    Dr. Carlos A Mora, MD Ana C Londono

  4. Memory binding and white matter integrity in familial Alzheimer’s disease

    Article • Brain, March 2015, Oxford University Press (OUP)

    MD Ana C Londono

  5. Non-conventional MRI in multiple sclerosis

    Article • Neurology Neuroimmunology & Neuroinflammation, November 2014, Wolters Kluwer Health

    Dr. Carlos A Mora, MD Ana C Londono

  6. An 1H-MRS framework predicts the onset of Alzheimer's disease symptoms in PSEN1 mutation carriers

    Article • Alzheimer s & Dementia, September 2014, Elsevier

    MD Ana C Londono, Associate Professor Brett A Lidbury

  7. Analysis of brain metabolism by proton magnetic resonance spectroscopy (1H-MRS) in attention-deficit/hyperactivity disorder suggests a generalized differential ontogenic pattern from controls

    Article • ADHD Attention Deficit and Hyperactivity Disorders, July 2012, Springer Science + Business Media

    MD Ana C Londono

  8. A cooperative interaction between LPHN3 and 11q doubles the risk for ADHD

    Article • Molecular Psychiatry, May 2011, Nature

    MD Ana C Londono

  9. A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication

    Article • Molecular Psychiatry, February 2010, Nature

    MD Ana C Londono